Clinical Trials on Immune Suppression in New Zealand

Total 8394 results

NYU Langone Health
CSL Behring

Completed

C1-Inhibitor (INH) for Refractory Antibody Mediated Renal Allograft Rejection

Antibody Mediated Rejection of Kidney Transplant

United States
Xiu-Min Li
National Center for Complementary and Integrative Health (NCCIH)

Completed

Safety Study of Chinese Herbal Therapy to Treat Asthma

Asthma

United States
Icahn School of Medicine at Mount Sinai
Apple Inc.; Sage Bionetworks; Lifemap Solutions, Inc

Completed

Asthma Mobile Health Application 2.0

Asthma

United States
Research Foundation for Mental Hygiene, Inc.

Completed

Reducing Unsafe Alcohol Use in HIV-Positive Individuals

Alcohol Abuse

United States
Far Eastern Memorial Hospital

Completed

Rapid Urease Test for Diagnosis of H. Pylori Infection in Patients With Peptic Ulcer Bleeding

Hemorrhage | Peptic Ulcer

Taiwan
Beth Israel Medical Center

Completed

The Effects of Music Therapy as a Complementary Intervention in the Treatment of Pediatric Asthma

Asthma

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma

Lymphoma

United States
Accenture

Completed

Single Dose Study of GSK1440115 in Patients With Asthma

Asthma

Australia
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children

HIV Infections

United States, Puerto Rico
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Mechanisms of Ultrasound Neuromodulation Effects in Diabetes

Insulin Sensitivity

United States
Albert Einstein College of Medicine
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

ED2PrEP - Patient Focused, Low-burden Strategies for PrEP Uptake Among Emergency Departments (ED2PrEP)

HIV

United States
Gilead Sciences

Recruiting

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy (ARTISTRY-2)

HIV-1-infection

United States, Puerto Rico
Société des Produits Nestlé (SPN)

Completed

Extensively Hydrolyzed Formula: Hypoallergenicity

Food Hypersensitivity

United States
State University of New York at Buffalo
Gilead Sciences

Active, not recruiting

Bictegravir in the Elderly Living With HIV (BICEP)

HIV-1-infection

United States
NYU Langone Health
Arthritis Foundation

Recruiting

Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate Responders (EASi-RAIR)

Rheumatoid Arthritis

United States
Pfizer

Active, not recruiting

A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Pfizer

Completed

Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR)

Rheumatoid Arthritis

United States
NYU Langone Health

Active, not recruiting

A Pilot Proof of Concept Study of the Effects of Administration of SCFA in Rheumatoid Arthritis (EASi-RA)

Rheumatoid Arthritis

United States
Pfizer

Completed

Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTX

Rheumatoid Arthritis

United States
Pfizer

Completed

A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day

Arthritis Rheumatoid

United States
Pfizer

Completed

To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.

Rheumatoid Arthritis

United States
Weill Medical College of Cornell University
Millennium Pharmaceuticals, Inc.

Completed

Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL

Non-Hodgkin's Lymphoma

United States
Hunter College of City University of New York
Fordham University

Completed

Intervention Targeting Substance Using Older Adults With HIV

HIV | Medication Adherence | Substance Dependence

United States
EVIVE Biotechnology
Memorial Sloan Kettering Cancer Center

Completed

Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD

Acute Graft vs Host Disease

United States
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)

Hiv

United States
Creighton University
Novartis Pharmaceuticals

Completed

Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair

Lung Disease

United States
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institute of Mental Health...

Completed

Managerial Database II

HIV

United States, Puerto Rico
Memorial Sloan Kettering Cancer Center
Yale University; Dana-Farber Cancer Institute

Active, not recruiting

A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia

Leukemia | Leukemia, Hairy Cell | Hairy Cell Leukemia

United States
State University of New York - Upstate Medical...

Recruiting

Using Doxepin for Urticaria

Urticaria

United States
Polaris Health Directions
University of Massachusetts, Worcester

Completed

Substance Treatment and HIV Testing and Referral System (STaRS)

Substance Abuse

United States
Dartmouth-Hitchcock Medical Center

Withdrawn

Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma

Neoplasms | Lymphoma

United States
Gilead Sciences

Completed

Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Adolescents

HIV

United States, South Africa
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Columbia University; Emory University; Rutgers...

Completed

Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Lymphoma | Leukemia

United States
NYU Langone Health
National Multiple Sclerosis Society

Recruiting

Cognitive Markers in Prodromal MS

Multiple Sclerosis

United States
Icahn School of Medicine at Mount Sinai

Completed

Assessing Inflammatory and Behavioral Pathways Linking PTSD to Increased Asthma Morbidity in WTC Workers

PTSD | Asthma

United States
NYU Langone Health
Stony Brook University

Completed

Pilot Study of Transcranial Direct Current Stimulation (tDCS)

Multiple Sclerosis

United States
Memorial Sloan Kettering Cancer Center
National Institutes of Health (NIH)

Completed

Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes

Head and Neck Cancers

United States
Memorial Sloan Kettering Cancer Center
Genentech, Inc.

Terminated

Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma

Hodgkin Lymphoma

United States
Yale University
National Cancer Institute (NCI)

Active, not recruiting

A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV (SMARTTT)

Tobacco Use Cessation

United States
University of California, San Diego
National Institute of Mental Health (NIMH); New York State Psychiatric Institute

Recruiting

Pramipexole to Enhance Social Connections

Depression | Anxiety Disorders | Anxiety | Social Disconnection

United States
Biogen

Terminated

Study of Diroximel Fumarate in the Real-World Setting

Relapsing Forms of MS

United States
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.

Completed

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection

HIV Infections

United States
Northwell Health

Terminated

Hydroxychloroquine in Untreated B-CLL Patients

B-Cell Chronic Lymphocytic Leukemia

United States
Memorial Sloan Kettering Cancer Center

Recruiting

Looking at Brain Changes in People With Lymphoma Receiving CAR-T Therapy

Lymphoma Receiving CAR-T Therapy

United States
Columbia University

Completed

Does Potassium Iodide (SSKI) Reduce Vascularity in Graves' Thyroidectomy?

Graves Disease

United States
BeCare Link LLC
Weill Medical College of Cornell University

Enrolling by invitation

Patient Centered Outcomes Analysis for MS Using a Mobile Application

Multiple Sclerosis

United States
Memorial Sloan Kettering Cancer Center
Columbia University; University of Vermont; University of Virginia; Northwestern... and other collaborators

Completed

Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Lymphoma

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

Lymphoma | Leukemia

United States
Memorial Sloan Kettering Cancer Center
Children's Cancer Group

Completed

A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)

Pediatric | Hodgkin's Disease

United States
Centers for Disease Control and Prevention

Completed

Adopting and Demonstrating the Adaptation of Prevention Techniques (ADAPT), Harlem United Community AIDS Center

HIV Infections | Sexually Transmitted Diseases

United States

Clinical Trials on Immune Suppression in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations